Correction to: British Journal of Cancer (2008) 99, 1874–1883. doi:10.1038/sj.bjc.6604740
During final submission of this paper, the authors very regretfully failed to acknowledge some of the support given to them during the completion of their study. Their full and complete Acknowledgments are given below:
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Acknowledgements
The excellent technical assistance of Bernadette Bournonville and Chantal Degraef is greatly appreciated. The kind help of Danièle Leemans-De Vos for secretarial task is also acknowledged. This work was supported by Fondation Van Buuren; Fondation Tournay-Solvay; GENERISK-T: Genetic component of the low dose risk of thyroid cancer; FRSM: Fonds Recherche Scientifique Médicale; ARC: Actions de Recherche Concertées de la Communauté Francaise de Belgique.
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6604740
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Jin, L., Burniat, A., Dumont, JE. et al. Erratum: Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice. Br J Cancer 100, 1013 (2009). https://doi.org/10.1038/sj.bjc.6604991
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6604991
